Contents

Preface : The Second Anniversary

Abstract

Introduction

Academia - Industry Proximity

Increasing Connection

‘Patient or Product’ Loyalty

Ambivalence About Industry Funding

Funds, Research Agendas, and Profit Maximization

R and D in Pharmaceutical Companies

Ethical Concerns and the Pseudo-Educational Dollar

Negative Implications of this Trend

Rationalizations abound

Needs of Academia and Industry

Growing Scale of Research

Conflict in Expectations, Competing Interests and Priorities

 1. The Public

 2. The Patients

 3. Companies, large and small

 4. Venture capital

 5. Stocks and Equity

Concluding Remarks

References

Questions that this monograph raises

Readers Respond

Abraham Verghese, J.K. Trivedi